- Home
- LKFN vs ARWR Comparison
LKFN vs ARWR Comparison
Compare LKFN & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LKFN
- ARWR
- Stock Information
- Founded
- LKFN 1872
- ARWR 2003
- Country
- LKFN United States
- ARWR United States
- Employees
- LKFN N/A
- ARWR N/A
- Industry
- LKFN Major Banks
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- LKFN Finance
- ARWR Health Care
- Exchange
- LKFN Nasdaq
- ARWR Nasdaq
- Market Cap
- LKFN 1.6B
- ARWR 1.8B
- IPO Year
- LKFN 1997
- ARWR 1993
- Fundamental
- Price
- LKFN $60.41
- ARWR $16.81
- Analyst Decision
- LKFN Buy
- ARWR Buy
- Analyst Count
- LKFN 2
- ARWR 10
- Target Price
- LKFN $65.00
- ARWR $42.13
- AVG Volume (30 Days)
- LKFN 111.5K
- ARWR 1.9M
- Earning Date
- LKFN 07-24-2025
- ARWR 05-12-2025
- Dividend Yield
- LKFN 3.34%
- ARWR N/A
- EPS Growth
- LKFN N/A
- ARWR N/A
- EPS
- LKFN 3.50
- ARWR N/A
- Revenue
- LKFN $236,268,000.00
- ARWR $545,209,000.00
- Revenue This Year
- LKFN $16.03
- ARWR $21,924.50
- Revenue Next Year
- LKFN $4.31
- ARWR N/A
- P/E Ratio
- LKFN $17.26
- ARWR N/A
- Revenue Growth
- LKFN N/A
- ARWR 1436.97
- 52 Week Low
- LKFN $50.00
- ARWR $9.57
- 52 Week High
- LKFN $78.61
- ARWR $30.41
- Technical
- Relative Strength Index (RSI)
- LKFN 55.39
- ARWR 62.87
- Support Level
- LKFN $58.38
- ARWR $16.06
- Resistance Level
- LKFN $60.53
- ARWR $17.08
- Average True Range (ATR)
- LKFN 1.48
- ARWR 0.77
- MACD
- LKFN -0.16
- ARWR 0.07
- Stochastic Oscillator
- LKFN 81.96
- ARWR 83.26
About LKFN Lakeland Financial Corporation
Lakeland Financial Corp is a bank holding company. It provides commercial, retail, wealth advisory, and investment management services. It offers a broad line of products and services throughout its Northern and Central Indiana markets. The company provides commercial and consumer banking services, as well as trust and wealth management, brokerage, and treasury management commercial services. It serves a wide variety of industries including, among others, commercial real estate, manufacturing, agriculture, construction, retail, wholesale, finance and insurance, accommodation and food services, and healthcare.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.